ACET insider trading
NasdaqCM HealthcareAdicet Bio, Inc.: insider trade history from SEC Form 4 filings.
About Adicet Bio, Inc.
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.
Company website: www.adicetbio.com
ACET insider activity at a glance
FilingIQ tracks 486 insider transactions for ACET in filings since Feb 12, 2015. The most recent transaction is dated Apr 27, 2026.
Across the full history, 24 open-market purchases
and 219 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ACET insider trades is 59.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ACET Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for ACET?
- FilingIQ tracks 486 Form 4 insider transactions for ACET (Adicet Bio, Inc.), covering filings from Feb 12, 2015 onwards. 0 of those are dated within the last 90 days.
- Are ACET insiders net buyers or net sellers?
- Across the full Form 4 history for ACET, 24 transactions (5%) were open-market purchases and 219 (45%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ACET insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is ACET in?
- Adicet Bio, Inc. (ACET) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $65.38M.
Methodology & sources
Every ACET insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.